Renaissance Technologies LLC boosted its position in Stericycle, Inc. (NASDAQ:SRCL) by 718.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,249,020 shares of the company’s stock after buying an additional 1,096,400 shares during the period. Renaissance Technologies LLC owned about 1.47% of Stericycle worth $96,225,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Capital Analysts LLC boosted its position in shares of Stericycle by 6.2% in the fourth quarter. Capital Analysts LLC now owns 1,294 shares of the company’s stock valued at $100,000 after buying an additional 76 shares during the period. Pacad Investment Ltd. bought a new position in shares of Stericycle during the fourth quarter valued at about $100,000. Balentine LLC boosted its position in shares of Stericycle by 15.0% in the second quarter. Balentine LLC now owns 1,224 shares of the company’s stock valued at $127,000 after buying an additional 160 shares during the period. NEXT Financial Group Inc boosted its position in shares of Stericycle by 78.0% in the third quarter. NEXT Financial Group Inc now owns 1,620 shares of the company’s stock valued at $130,000 after buying an additional 710 shares during the period. Finally, Fuller & Thaler Asset Management Inc. bought a new position in shares of Stericycle during the third quarter valued at about $136,000. Institutional investors and hedge funds own 94.49% of the company’s stock.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Stericycle, Inc. (NASDAQ:SRCL) traded up 7.70% during midday trading on Thursday, reaching $83.35. The company had a trading volume of 4,370,541 shares. Stericycle, Inc. has a 52-week low of $71.52 and a 52-week high of $128.94. The company’s 50 day moving average is $77.98 and its 200-day moving average is $78.79. The company has a market capitalization of $7.09 billion, a P/E ratio of 30.30 and a beta of 0.08.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Wednesday, February 15th. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.93 by $0.07. Stericycle had a net margin of 7.52% and a return on equity of 15.33%. The company had revenue of $906.40 million for the quarter, compared to analyst estimates of $902.62 million. During the same quarter last year, the business earned $1.11 earnings per share. Equities analysts expect that Stericycle, Inc. will post $4.46 earnings per share for the current fiscal year.

“Stericycle, Inc. (SRCL) Shares Bought by Renaissance Technologies LLC” was first published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this article can be accessed at http://www.watchlistnews.com/stericycle-inc-srcl-shares-bought-by-renaissance-technologies-llc/1120920.html.

Several research firms have issued reports on SRCL. Jefferies Group LLC set a $108.00 target price on Stericycle and gave the stock a “buy” rating in a research report on Tuesday, October 25th. Stifel Nicolaus upgraded Stericycle from a “hold” rating to a “buy” rating and set a $90.00 target price on the stock in a research report on Friday, October 28th. Goldman Sachs Group, Inc. (The) cut Stericycle from a “neutral” rating to a “sell” rating and set a $60.00 target price on the stock. in a research report on Thursday, November 3rd. Zacks Investment Research upgraded Stericycle from a “strong sell” rating to a “hold” rating in a research report on Monday, October 31st. Finally, Wedbush reiterated a “neutral” rating and set a $82.00 target price (down previously from $85.00) on shares of Stericycle in a research report on Tuesday, November 15th. Five equities research analysts have rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $92.83.

In other Stericycle news, Director Mark C. Miller sold 6,677 shares of the firm’s stock in a transaction that occurred on Tuesday, December 13th. The shares were sold at an average price of $76.23, for a total value of $508,987.71. Following the sale, the director now owns 216,126 shares in the company, valued at $16,475,284.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert S. Murley purchased 1,000 shares of the company’s stock in a transaction on Wednesday, February 1st. The stock was purchased at an average price of $76.22 per share, for a total transaction of $76,220.00. The disclosure for this purchase can be found here. 3.30% of the stock is currently owned by company insiders.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL).

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.